The DISI tablet disintegration tester combines a proven design with new innovative concepts of data acquisition and data analysis. DISI has been developped in conjunction with the well-known PH21 pharmaceutical production control software system. The USP/EP-conform DISI-models are available with 1, 2, 3 and 4 test stations. All models are equipped with independently operating test stations, arranged adjacent to each other.
All operations of the DISI are performed via the PC's Windows-based human machine operating interface. The system corresponds to the latest requirements of FDA 21CFR Part 11.

http://www.ischi.ch